These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23062706)

  • 1. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
    Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
    Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype.
    Pilewskie M; Zabor EC; Mamtani A; Barrio AV; Stempel M; Morrow M
    Ann Surg Oncol; 2017 Nov; 24(12):3527-3533. PubMed ID: 28762114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast radiotherapy (RT) using tangential fields (TgF): a prospective evaluation of the dose distribution in the sentinel lymph node (SLN) area as determined intraoperatively by clip placement.
    Belkacemi Y; Bigorie V; Pan Q; Bouaita R; Pigneur F; Itti E; Badaoui H; Assaf E; Caillet P; Calitchi E; Bosc R
    Ann Surg Oncol; 2014 Nov; 21(12):3758-65. PubMed ID: 25096388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07).
    van Roozendaal LM; de Wilt JH; van Dalen T; van der Hage JA; Strobbe LJ; Boersma LJ; Linn SC; Lobbes MB; Poortmans PM; Tjan-Heijnen VC; Van de Vijver KK; de Vries J; Westenberg AH; Kessels AG; Smidt ML
    BMC Cancer; 2015 Sep; 15():610. PubMed ID: 26335105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer.
    Mamtani A; Patil S; Stempel M; Morrow M
    Ann Surg Oncol; 2017 Aug; 24(8):2182-2188. PubMed ID: 28429197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management.
    Qiu PF; Zhao RR; Wang W; Sun X; Chen P; Liu YB; Liu ZG; Wang YS
    Ann Surg Oncol; 2020 Feb; 27(2):375-383. PubMed ID: 31407178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Positive Sentinel Lymph Node After Neoadjuvant Systemic Therapy in Clinically Node-Negative Breast Cancer: Implications for Postmastectomy Radiation Therapy and Immediate Breast Reconstruction.
    Samiei S; van Kaathoven BN; Boersma L; Granzier RWY; Siesling S; Engelen SME; de Munck L; van Kuijk SMJ; van der Hulst RRJW; Lobbes MBI; Smidt ML; van Nijnatten TJA
    Ann Surg Oncol; 2019 Nov; 26(12):3902-3909. PubMed ID: 31359276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
    Donker M; van Tienhoven G; Straver ME; Meijnen P; van de Velde CJ; Mansel RE; Cataliotti L; Westenberg AH; Klinkenbijl JH; Orzalesi L; Bouma WH; van der Mijle HC; Nieuwenhuijzen GA; Veltkamp SC; Slaets L; Duez NJ; de Graaf PW; van Dalen T; Marinelli A; Rijna H; Snoj M; Bundred NJ; Merkus JW; Belkacemi Y; Petignat P; Schinagl DA; Coens C; Messina CG; Bogaerts J; Rutgers EJ
    Lancet Oncol; 2014 Nov; 15(12):1303-10. PubMed ID: 25439688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten year results of conservative surgery and irradiation for stage I and II breast cancer.
    Fowble BL; Solin LJ; Schultz DJ; Goodman RL
    Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):269-77. PubMed ID: 1648040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Nodal Irradiation in Early-Stage Breast Cancer.
    Whelan TJ; Olivotto IA; Parulekar WR; Ackerman I; Chua BH; Nabid A; Vallis KA; White JR; Rousseau P; Fortin A; Pierce LJ; Manchul L; Chafe S; Nolan MC; Craighead P; Bowen J; McCready DR; Pritchard KI; Gelmon K; Murray Y; Chapman JA; Chen BE; Levine MN;
    N Engl J Med; 2015 Jul; 373(4):307-16. PubMed ID: 26200977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional nodal irradiation in the conservative treatment of breast cancer.
    Haffty BG; Fischer D; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):859-65. PubMed ID: 2211254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis for breast cancer surgery and radiation therapy compared with mastectomy alone. A retrospective analysis of 759 patients with stage I/II breast cancer.
    Janjan NA; Murray KJ; Conway P; Walker A; Wilson JF
    Cancer; 1992 Jun; 69(11):2842-8. PubMed ID: 1571915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using MammaPrint on core needle biopsy to guide the need for axillary staging during breast surgery.
    Drapalik LM; Miller ME; Rock L; Li P; Simpson A; Shenk R; Amin AL
    Surgery; 2024 Mar; 175(3):579-586. PubMed ID: 37852835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary dissection in breast cancer revisited.
    Mattheiem W; Bourgeois P; Delcorde A; Stegen M; Frühling J
    Eur J Surg Oncol; 1989 Dec; 15(6):490-5. PubMed ID: 2599119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in breast cancer.
    Alsaif AA
    Saudi Med J; 2015 Sep; 36(9):1053-60. PubMed ID: 26318461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of conservative therapy for invasive breast cancer by histologic subtype.
    Weiss MC; Fowble BL; Solin LJ; Yeh IT; Schultz DJ
    Int J Radiat Oncol Biol Phys; 1992; 23(5):941-7. PubMed ID: 1322387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage I and II breast carcinoma: treatment with limited surgery and radiation therapy versus mastectomy.
    Komaki R; Cox JD; Kister SJ; Gump FE; Estabrook A
    Radiology; 1990 Jan; 174(1):255-7. PubMed ID: 2104676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome.
    Recht A; Come SE; Gelman RS; Goldstein M; Tishler S; Gore SM; Abner AL; Vicini FA; Silver B; Connolly JL
    J Clin Oncol; 1991 Sep; 9(9):1662-7. PubMed ID: 1875223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The primary surgical treatment of carcinoma of the breast: a changing trend toward modified radical mastectomy.
    Robinson GN; van Heerden JA; Payne WS; Taylor WF; Gaffey TA
    Mayo Clin Proc; 1976 Jul; 51(7):433-42. PubMed ID: 933559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical mastectomy with parasternal node dissection or radiation to the parasternal region for breast cancer of medial or central location.
    Shiba E; Miyauchi K; Kobayashi T; Takai S; Mori T
    Surg Today; 1992; 22(2):124-7. PubMed ID: 1498490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.